Document:

Unassociated Document

    SECOND
      AMENDMENT TO PROMISSORY NOTE

    

    

    Whereas,
      that certain Promissory Note dated October 24, 2006, in the original principal
      amount of $1,700,000 was executed by iSecureTrac Corp. (“Maker”) in favor of
      Consolidated Investment Services, Inc. (“Payee”) which note was amended by that
      First Amendment dated December 12, 2006 (the note as amended by said first
      amendment is hereinafter referred to as the “Note”); and

    

    Whereas,
      Maker and Payee now desire to amend the Note to modify the Maturity Date (as
      defined in the Note);

    

    NOW
      THEREFORE, for and in consideration of ten dollars and other good and valuable
      consideration receipt of which is hereby acknowledged, it is hereby agreed
      as
      follows:

    

    1. The
      “Maturity Date” as defined in the Note is hereby amended and restated as
      follows:

    

    “Maturity
      Date.”
The
      earlier of (i) July 1, 2009; or (ii) the first date on which Maker issues equity
      securities or arranges for additional indebtedness (other than trade
      indebtedness incurred in the ordinary course of its business) in a transaction
      or series of transactions which generates aggregate net proceeds to the Maker
      of
      not less than $1,700,000.

    

    2. Except
      as
      amended hereby, the Note remains the same in all respects and remains in full
      force and effect.

    

    Signed
      this 9th day of May, 2007.

    
      	 	 
	 	 
	 	
              MAKER:

            
	 	 
	 	
              ISECURETRAC
                CORP.,

            
	 	
              a
                Delaware corporation

            
	 	 
	 	
              By:
                /s/ Peter A. Michel

            
	 	
              Name:
                Peter A. Michel

            
	 	
              Its:
                CEO

            
	 	
              Federal
                ID #: 87-0347787

            
	 	 
	 	 
	 	
              PAYEE:

            
	 	 
	 	
              CONSOLIDATED
                INVESTMENT SERVICES, INC.,

            
	 	
              a
                Nevada corporation

            
	 	 
	 	
              By:
                /s/ Heather Kreager

            
	 	
              Name:
                Heather Kreager

            
	 	
              Its:
                Vice President

            
	 	
              Federal
                ID #: 88-0214301AMENDMENT
      TO THE AMENDED AND 

    RESTATED
      CONSULTING AGREEMENT

    

    THIS
      AMENDMENT (“Amendment”) effective December 21, 2005 (“Amendment Effective Date”)
      is to the existing amended and restated Consulting Agreement (the “Agreement”)
      dated August 8, 2005 (the “Effective Date’) between James A. Wells, Ph.D.
      (“Consultant”) and Sunesis Pharmaceuticals Inc. (“Sunesis”). All capitalized
      terms herein shall have the same meaning as set forth in the
      Agreement.

    

    WHEREAS,
      the parties hereto desire to modify the existing Agreement to provide the terms
      and conditions upon which Consultant may continue to provide consulting services
      to Sunesis.

    

    THEREFORE,
      in consideration of the promises and mutual covenants contained in this
      Amendment, the parties hereby agree to the terms and conditions set forth
      below.

    

    
      	
            	1.	
              Section
                2 of the Agreement is deleted in its entirety and replaced with the
                following section:

            

    

    

    
      	“2.	
              Compensation.
                

            

    

    

    A.
       Cash.
      As
      consideration for Consultant’s performance of Services, Sunesis shall make cash
      payments to ‘The Regents of the University of California’ on behalf of
      Consultant as set forth below.

    

    i)  For
      SAB Responsibilities:
      Consultant shall receive $1,500 per day for participation at each SAB
      Meeting.

    

    ii)  For
      Consulting Responsibilities:
      Consultant shall be paid $5,000 for two (2) days of consulting per month
      (approx. 1⁄2 day per week per month). Additional consulting days will be paid at a
      rate of $3,000 per day (assuming an eight (8) hour day). Sunesis will make
      payments for Services performed under this paragraph 2.A.ii) on a monthly basis
      thirty (30) days after Sunesis’ receipt of Consultant’s invoice. 

    

    B. Stock
      Options.
      Separately, any Incentive Stock Options (ISOs) granted by Sunesis to Consultant
      while he was an employee will be converted to Non-Qualified Stock Options
      (NQSOs), and all unvested stock options will continue to vest during the next
      twelve (12) months in accordance with the normal vesting schedule for each
      grant. At the end of the 12- month period following the Effective Date vesting
      will end.”

    

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

     

    

     

    Except
      as
      otherwise stated in this Amendment, all other terms and conditions of the
      original Agreement shall remain in full force and effect.

    

    IN
      WITNESS WHEREOF, the parties have executed this Amendment to be executed as
      of
      the Amendment Effective Date.  

      

    
      	Sunesis
              Pharmaceuticals, Inc.	 	 	Consultant
	341 Oyster Point Boulevard	 	 	1341 Columbus Avenue
	South San Francisco, California
              94080	 	 	Burlingame, California
              94010

    

     

    
      	 	 	 	 
	By:	 	 	By:
	
              
                

              

              Daryl
                B. Winter, Ph.D.

              Senior
                Vice President, General

              Counsel

            	 	 	
              
                

              

              James
                A. Wells, Ph.D.

            
	
            	 	 	
            
	Date Signed:	 	 	Date Signed:
	
              
                

              

            	 	 	
              
                
 

            

    

     

    
      
         

      

      
        2Homer
      L.
      Pearce, Ph.D.

    84
      Clifden Pond Road

    Zionsville,
      IN 46077

    

    Re: Letter
      Agreement for Consulting Services (“Letter Agreement”)

    

    Dear
      Dr.
      Pearce:

    

    We
      are
      pleased that you have agreed to enter into a consulting relationship with
      Sunesis. This letter serves as formal agreement between you and Sunesis and
      sets
      forth the terms and conditions of the consulting relationship. 

    

    
      	A.	
              Consulting
                Services and Compensation.

            

    

    

    Consulting
      services to be provided by you to Sunesis shall include, but not be limited
      to:

     

    
      	
            	·	
              Participate
                in the review and discussion of Sunesis’ Research and Development
                strategy.

            

    

    

    
      	
            	·	
              Review
                and assess development plans and status of Sunesis compounds, i.e.
                SNS-595, SNS-032, SNS-314, and provide advice to Sunesis
                management.

            

    

    

    
      	
            	·	
              Participate
                in selected advisory and project
                meetings.

            

    

    

    In
      consideration for your consulting services, Sunesis will compensate you $3,000
      per day (or prorated at a hourly rate of $375/hour). In addition to the
      foregoing, Sunesis will reimburse you for any out-of-pocket expenses reasonably
      incurred while performing consulting services on behalf of Sunesis. Payments
      hereunder shall be based on Sunesis’ receipt from you of an itemized invoice for
      services and expenses, including related documentation for such expenses.
      Sunesis will pay such invoice within thirty (30) days of receipt. The total
      payments to be made pursuant to this Letter Agreement during any given one
      (1)
      year period shall not exceed $40,000.
      

    

    
      	B.	
              Confidentiality
                and Inventions. The
                provisions for confidentiality and ownership of inventions in connection
                with your consulting services hereunder are governed by the terms
                and
                conditions set forth under your signed Confidential
                Information and Invention Assignment Agreement dated
                June 22, 2006,
                which is appended to this Letter Agreement as Attachment
                A.

            

    

     

    
      	C.	
              Term
                and Termination. The
                term of your consulting services shall commence on the date of your
                acceptance of this Letter Agreement and continue for as long as you
                remain
                a member of Sunesis’ Board of Directors. Either you or Sunesis may
                terminate this Letter Agreement any time upon prior written
                notice. 

            

    

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    
      	D.	
              Independent
                Contractor.
                You agree that your relationship with SUNESIS will be that of an
                independent contractor and not that of an employee of Sunesis. You
                will
                not be eligible for any employee benefits or unemployment benefits,
                nor
                will Sunesis make deductions from payments made to you for taxes,
                unless
                otherwise stated below or as required by law, all of which will be
                your
                responsibility. California tax(es) will be deducted pursuant to California
                State Franchise Tax Board Publication 1023 for all non-resident
                consultants unless the appropriate exemption forms are completed
                and
                provided to SUNESIS

            

    

    

    
      	E.	
              No
                Conflict.
                You represent that neither the execution of this Letter Agreement
                nor the
                performance of your obligations under this Letter Agreement will
                result in
                a violation or breach of any other agreement by which you are bound.
                During the term of this Letter Agreement, you agree not to enter
                into a
                binding agreement that would conflict with any of the provisions
                of this
                Letter Agreement and/or preclude you from complying with the provisions
                hereof. 

            

    

    

    This
      Letter Agreement, including Attachment
      A,
      constitutes the entire agreement between you and Sunesis with respect to your
      consulting services and supersedes all prior written and oral agreements
      regarding the subject matter. This Letter Agreement shall be governed, construed
      and enforced by the laws of the State of California, without giving effect
      to
      the principles of conflict of laws.

     

    To
      indicate your acceptance of this Letter Agreement, please sign and date this
      letter in the space provided below and return it to me. On behalf of Sunesis
      and
      its management team, we all look forward to a successful working relationship.
      

    
      	 	 	 
	 	Sincerely,
	 	 
	 	
              
                SUNESIS
                  PHARMACEUTICAL
                  INC.

              

            
	 	 
	 	 
	 	Daniel N. Swisher, Jr.
	 	Chief Executive Officer and
              President

    

     

    ACCEPTED
      AND AGREED TO BY:

     

     

      
        

      

    

    Homer
      L.
      Pearce, Ph.D.

    

    
      

    

    Tax
      ID/Social Security Number

    

    Dated
      Signed:

    
      

    

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    ATTACHMENT
      A

     

    
      SUNESIS
        PHARMACEUTICALS, INC.

       

      CONFIDENTIAL
        INFORMATION

      AND

      INVENTION
        ASSIGNMENT AGREEMENT

      

      In
        exchange for my becoming retained by Sunesis Pharmaceuticals, Inc. (the
“Company”) as a member of its Board of Directors (hereinafter, the
“Relationship”), I hereby agree to comply with the provisions set forth
        below.

       

      
        	1.	
                Confidential
                  Information

              

      

       

      
        	 	
                a.

              	
                Definition
                  of Confidential Information.
                  As used in this Agreement, the term “Confidential
                  Information”
                  means information pertaining to any aspects of the Company’s business,
                  including but not limited to its research, technical data, products,
                  services, plans for products or services, customers and potential
                  customers, markets and marketing, finances, financial projections,
                  employees (including employee compensation), patents, patent applications,
                  developments, inventions, processes, designs, drawings, engineering,
                  formulae, regulatory information, medical reports, clinical data
                  and
                  analysis, reagents, cell lines, biological materials, chemical
                  formulas,
                  business plans, and agreements with third parties, disclosed to
                  me by the
                  Company either directly or indirectly in writing, orally or by
                  drawings,
                  or by observation or created by me during the period of the Relationship,
                  whether or not during working hours. Notwithstanding the foregoing,
                  Confidential Information shall not include information
                  that

              

      

       

      
        	
              	(i)	
                was
                  in the public domain at the time it was disclosed or has entered
                  the
                  public domain through no fault of
                  mine;

              

      

       

      
        	
              	(ii)	
                was
                  previously known to me, without restriction, at the time of the
                  disclosure, as demonstrated by my files in existence at the time
                  of
                  disclosure; or

              

      

       

      
        	
              	(iii)	
                is
                  disclosed with the prior written approval of the
                  Company.

              

      

       

      
        	 	
                b.

              	
                Confidentiality
                  Obligations.
                  I
                  agree to hold in confidence and not directly or indirectly to use
                  or
                  disclose to any third person or entity, either during or after
                  termination
                  of the Relationship, any Confidential Information I obtain or create
                  during the period of the Relationship, whether or not during working
                  hours, except to the extent authorized by the Company, until such
                  Confidential Information becomes generally known by the public.
                  I agree
                  not to make copies of such Confidential Information except as authorized
                  by the Company.

              

      

       

      
        	 	
                c.

              	
                Return
                  of Confidential Information.
                  Upon termination of the Relationship or upon an earlier written
                  request of
                  the Company, I will return or deliver to the Company all tangible
                  forms of
                  such Confidential Information in my possession or control, including
                  any
                  copies or reproductions thereof.

              

      

       

      
        	 	
                d.

              	
                This
                  Section 1b shall not restrict me from disclosing Confidential Information
                  that I’m required to disclose pursuant to an order or requirement of a
                  court, administrative agency, or other governmental body; provided,
                  that I
                  shall promptly provide notice of such court order or requirement
                  to the
                  Company to enable the Company the opportunity to seek a protective
                  order
                  or otherwise prevent or restrict such
                  disclosure.

              

      

       

      
        
          
          

        

        
          1
            of
            1

          
            

          

        

        
          
          

        

      

       

      
        
          
            	2.	
                    Invention
                      Assignment

                  

          

        

      

       

      
        	 	
                a.

              	
                Inventions.
                  As used in this Agreement, the term “Inventions”
                  means designs, trademarks, discoveries, formulae, processes, manufacturing
                  techniques, trade secrets, inventions, developments, original works
                  of
                  authorship, concepts, know-how, improvements, and ideas, whether
                  or not
                  patentable or registrable under copyright or similar laws, including
                  all
                  rights to obtain, register, perfect and enforce these proprietary
                  interests.

              

      

       

      
        	 	
                b.

              	
                Assignment
                  of Inventions.
                  Without further compensation, I hereby agree promptly to disclose
                  to the
                  Company, and I hereby assign and agree to assign to the Company
                  or its
                  designee, my entire right, title, and interest throughout the world
                  in and
                  to all Inventions and all intellectual property rights thereto
                  that I may
                  conceive, develop or reduce to practice during the period of the
                  Relationship, whether or not during working hours, but limited
                  to
                  Inventions conceived of in connection with services performed on
                  behalf of
                  the Company that are related to duties carried out in service to
                  the
                  Relationship. 

              

      

       

      
        	
              	c.	
                Further
                  Assistance.
                  I
                  agree to perform, during and after the Relationship, all acts deemed
                  necessary or desirable by the Company to permit and assist it,
                  at the
                  Company’s expense, in obtaining and enforcing the full benefits,
                  enjoyment, rights and title throughout the world in the Inventions
                  and all
                  intellectual property rights thereto assigned to the Company as
                  set forth
                  in Section 2b above. Such acts may include, but are not limited to,
                  the disclosure to the Company of all information relating thereto,
                  the
                  execution of documents and assistance or cooperation in legal proceedings.
                  

              

      

       

      
        	
              	d.	
                Power
                  of Attorney.
                  If the Company is unable because of my mental or physical incapacity
                  or
                  unavailability or for any other reason to secure my signature to
                  apply for
                  or to pursue any application for any United States or foreign patents
                  or
                  copyright registrations covering Inventions assigned to the Company
                  as
                  above, then I hereby irrevocably designate and appoint the Company
                  and its
                  duly authorized officers and agents as my agent and attorney in
                  fact, to
                  act for and in my behalf to execute and file any such applications
                  and to
                  do all other lawfully permitted acts to further the application
                  for,
                  prosecution, issuance, maintenance or transfer of letters patent
                  or
                  copyright registrations thereon with the same legal force and effect
                  as if
                  originally executed by me. I hereby waive and irrevocably quitclaim
                  to the
                  Company any and all claims, of any nature whatsoever, that I now
                  or
                  hereafter have for infringement of any and all proprietary rights
                  assigned
                  to the Company.

              

      

       

      
        	
                3.

              	
                Miscellaneous

              

      

       

      
        	 	
                a.

              	
                No
                  Conflicts.
                  I
                  represent that my performance of all the terms of this Agreement
                  does not
                  and will not breach any agreement to keep in confidence proprietary
                  information, knowledge or data acquired by me in confidence or
                  in trust
                  prior to the Relationship, and I will not disclose to the Company,
                  or
                  induce the Company to use, any confidential or proprietary information
                  or
                  material belonging to any previous employer or any other third
                  party. I
                  agree not to enter into any written or oral agreement that conflicts
                  with
                  the provisions of this Agreement. I further represent that, to
                  the best of
                  my knowledge and belief, I am not a party to any other agreement,
                  which
                  will interfere with my full compliance with this
                  Agreement.

              

      

       

      
        
          
          

        

        
          2
            of
            2

          
            

          

        

        
          
          

        

      

       

      
        	 	
                b.

              	
                Solicitation
                  of Employees, Consultants and Other Parties.
                  I
                  agree that during the term of Relationship with the Company, and
                  for a
                  period of twenty-four (24) months following the termination of
                  the
                  Relationship for any reason, I shall not directly or indirectly
                  (i)
                  solicit, induce, recruit or encourage any of the Company’s employees or
                  consultants to terminate their relationship with the Company, or
                  attempt
                  any of the foregoing, either for myself or any other person or
                  entity; or
                  (ii) solicit any licensor to or customer of the Company or licensee
                  of the
                  Company’s products, that are known to me, with respect to any business,
                  products or services that are competitive to the products or services
                  offered by the Company or under development as of the date of termination
                  of the Relationship.

              

      

       

      
        	 	
                c.

              	
                Effects
                  of Agreement.
                  This Agreement (i) shall survive the termination of the Relationship,
                  (ii) does not in any way restrict my right or the right of the
                  Company to terminate the Relationship, with or without cause,
                  (iii) inures to the benefit of successors and assigns of the Company,
                  and (iv) is binding upon my heirs and legal
                  representatives.

              

      

       

      
        	
              	d.	
                Governing
                  Law.
                  This Agreement shall be governed by the laws of the State of California
                  applicable to contracts entered into and performed entirely within
                  the
                  State, without giving effect to principles of conflict of
                  laws.

              

      

       

      
        	
              	e.	
                Severability.
                  If any provision of this Agreement is held to be unenforceable
                  under
                  applicable law, then such provision shall be excluded from this
                  Agreement
                  only to the extent unenforceable, and the remainder of such provision
                  and
                  of this Agreement shall be enforceable in accordance with its
                  terms.

              

      

       

      
        	
              	f.	
                Entire
                  Agreement; Modification.
                  This Agreement supersedes any oral, written or other communications
                  or
                  agreements concerning the subject matter, and may be amended or
                  waived
                  only by a written instrument signed by the
                  parties.

              

      

       

      I
        certify
        and acknowledge that I have carefully read all of the provisions of this
        Agreement and that I understand and will fully and faithfully comply with
        such
        provisions.

       

      

      By: 

      
        
          

        

      

      Homer
        L.
        Pearce, PhD. 

       

      Date
        Signed: 

      
        

      

           

      
        
          
          

        

        
          3
            of
            3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}]]